Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19)
Somayaji et al., BMJ Open, doi:10.1136/bmjopen-2023-076142
https://c19early.org/somayaji.html